A Five-Gene Stromal-EMT Signature Predicts Prognosis, Immunotherapy Resistance, and Therapeutic Vulnerability in Bladder Cancer
The five-gene score is best interpreted not as a standalone universal prognostic classifier, but as a compact stromal-EMT and immune-suppression phenotype associated with inferior ICB response, which supports a framework linking prognosis, microenvironment biology, immunotherapy resistance, and therapeutic hypotheses i...